Prognostic Factors in Primary Breast Sarcomas: A Series of Patients With Long-Term Follow-Up
Laurent Zelek(Institut Gustave Roussy), Axel Le Cesne(Institut Gustave Roussy), Thomas Tursz(Institut Gustave Roussy), Xavier Pivot(Levi Strauss (United States)), M. Spielmann(Institut Gustave Roussy), F. Rochard(Institut Gustave Roussy), Philippe Terrier(Institut Gustave Roussy), C. Le Péchoux(Institut Gustave Roussy), J M Guinebretière(Institut Gustave Roussy), Antonio Llombart‐Cussac(MedSIR (Spain))
Cited by 219
Related Papers
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
|Journal of Clinical Oncology|2017|1.7k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k